Nick Mordwinkin
Corporate Officer/Principal bij KEZAR LIFE SCIENCES, INC.
Vermogen: - $ op 30-04-2024
Profiel
Nick Mordwinkin was the founder of Curium, a company founded in 2014, where he held the title of President from 2014 to 2016.
He is currently the Chief Business Officer at Kezar Life Sciences, Inc. since 2022.
Previously, he worked at Ultragenyx Pharmaceutical, Inc. from 2015 to 2020 as the Senior Director & Head-Corporate Strategy.
From 2020 to 2022, he was the Head-Development, Inflammation & Fibrosis at Gilead Sciences, Inc. Dr. Mordwinkin holds a doctorate degree from the University of Southern California and an undergraduate degree from Nova Southeastern University, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 01-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Nick Mordwinkin
| Bedrijven | Functie | Begin |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | 11-07-2022 |
Eerdere bekende functies van Nick Mordwinkin
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-06-2022 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-10-2020 |
| Curium | Oprichter | 01-12-2016 |
Opleiding van Nick Mordwinkin
| University of Southern California | Doctorate Degree |
| Nova Southeastern University, Inc. | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Curium |